2Feld JJ, Dinh H, Arenoyich T, et al. Autoimmone bepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology, 2005, 42(1):53-62.
3Czaja AJ, Freese DK. American emaciation for the study of liver disease. Diagnosis and treatment of autoimmune hepatitis. Hepatotogy, 2002, 36(5):479.
4Daiekos GN, Zaehou K, Liaskos C, et al. Autoantibo dies and defined target autoantigens in autoimmune hepatitis: an owriview. Ear J Intern Med, 2002,13(3) :293-303.
7Berg PA, Klein R. Autoimmune hepatitis and overlap syndrome: diagnosis. Praxis,2002,91(34):1 339-1 346.
8Felid JJ, Dinah H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hematology, 2005,42(1) :53-62.
9Moratoria P, Moratoria L, Guidim, et al. Chnical impact of non organ specific auto antibodies on the response to combined antiviral treatment in patients with hepatitis. Cling Infect Dis, 2005,40 (3) :501-507.
10Paust S, Cantor H. Regulatory T cells and autoimmune diseases. Immunol Rev,2005,20(4) :195-207.
5Czaja AJ,Freese DK; American Association for the Study of Liver Disease.Diagnosis and treatment of autoimmune hepatitis.Hepatology,2002,36:479-497.
6Heathcote EJ.Management of Primary biliary cirrhosis.The American Association for the Study of Liver Diseases Practice guidelines.Hepatology,2000,31:1005-1013.
7Wies I,Brunner S,Henninger J,et al.Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.Lancet,2000,355:1510-1515.
8Leuschner U.primary biliary cirrhosis-presentation and diagnosis[J].Clin Liver Dis,2003; 7:741-758.
9Heathcote E J.Management of primary biliary cirrhosis.The American association for the study of lire diseases practice guidelines[J].Hcpatology,2000; 31:1005-1013.
10Miyakawa H,Tanaka A,Kikuchi K et al.Detection of antimitochondrial autoantibodies in immunofluurescent AMAM2 negative patients with primary biliary cirrhosis using recombinant autoantigcns[J].Hcpatology,2001; 34:243-248.
10Feld J J,, Dinh H, Arenovich T, et al.Autoimmune bepatitis: effect of symptoms and cirrhosis on natural history and outcome[J].Hepatology, 2005, 42(1): 53-62.
